Insider Transactions in Q3 2025 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
Corazon (Corsee) D. Sanders Director |
SELL
Open market or private sale
|
Direct |
2,665
-100.0%
|
$898,105
$337.0 P/Share
|
|
Sep 05
2025
|
Corazon (Corsee) D. Sanders Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,665
+50.0%
|
$413,075
$155.68 P/Share
|
|
Sep 02
2025
|
Titus B. Ball Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
122
-100.0%
|
$39,772
$326.76 P/Share
|
|
Aug 14
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
39,936
-41.08%
|
$12,140,544
$304.7 P/Share
|
|
Aug 14
2025
|
Xiaobin Wu President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,936
+34.35%
|
$6,269,952
$157.35 P/Share
|
|
Aug 13
2025
|
Xiaobin Wu President and COO |
SELL
Open market or private sale
|
Direct |
49,858
-29.51%
|
$15,106,974
$303.99 P/Share
|
|
Aug 13
2025
|
Xiaobin Wu President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,858
+42.6%
|
$8,226,570
$165.05 P/Share
|
|
Aug 13
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
11,013
-91.18%
|
$3,303,900
$300.4 P/Share
|
|
Aug 13
2025
|
Chan Henry Lee SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,230
+40.93%
|
$1,448,480
$176.75 P/Share
|
|
Aug 01
2025
|
Aaron Rosenberg Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,190
-100.0%
|
$345,100
$290.47 P/Share
|
|
Jul 30
2025
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
259
-100.0%
|
$78,995
$305.0 P/Share
|
|
Jul 30
2025
|
Chan Henry Lee SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
920
-100.0%
|
$279,680
$304.6 P/Share
|
|
Jul 29
2025
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
4,041
-55.25%
|
$1,224,423
$303.03 P/Share
|
|
Jul 18
2025
|
Lai Wang Global Head of R&D |
SELL
Open market or private sale
|
Indirect |
700
-100.0%
|
$210,000
$300.0 P/Share
|
|
Jul 09
2025
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
27,802
-63.75%
|
$7,033,906
$253.58 P/Share
|